These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7946806)

  • 1. Insights from animal models of myocardial infarction: do ACE inhibitors limit the structural response?
    Smits JF; Daemen MJ
    Br Heart J; 1994 Sep; 72(3 Suppl):S61-4. PubMed ID: 7946806
    [No Abstract]   [Full Text] [Related]  

  • 2. The renin-angiotensin system in left ventricular remodeling.
    Blaufarb IS; Sonnenblick EH
    Am J Cardiol; 1996 May; 77(13):8C-16C. PubMed ID: 8638527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of post-infarction left ventricular remodeling by ACE-inhibitors.
    St John Sutton M; Pfeffer MA
    Cardiologia; 1994 Dec; 39(12 Suppl 1):27-30. PubMed ID: 7634281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
    Beckwith C; Munger MA
    Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The renin-angiotensin system and cardiac remodelling after acute myocardial infarction.
    Ikram H
    Heart; 1996 Nov; 76(3 Suppl 3):68-72. PubMed ID: 8983667
    [No Abstract]   [Full Text] [Related]  

  • 6. Left ventricular remodeling following myocardial infarction.
    Pfeffer MA
    Cardiologia; 1994 Dec; 39(12 Suppl 1):25-6. PubMed ID: 7634276
    [No Abstract]   [Full Text] [Related]  

  • 7. The time course of left ventricular remodeling after acute myocardial infarction.
    Glasser SP
    Am J Cardiol; 1997 Aug; 80(4):506-7. PubMed ID: 9285666
    [No Abstract]   [Full Text] [Related]  

  • 8. Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction.
    Westendorp B; Schoemaker RG; Buikema H; de Zeeuw D; van Veldhuisen DJ; van Gilst WH
    J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):27-32. PubMed ID: 15136971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug differences between ACE inhibitors in experimental settings and clinical practice.
    Voors AA; Kingma JH; van Gilst WH
    J Cardiovasc Risk; 1995 Oct; 2(5):413-22. PubMed ID: 8749268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination angiotensin converting enzyme and direct renin inhibition in heart failure following experimental myocardial infarction.
    Connelly KA; Advani A; Advani S; Zhang Y; Thai K; Thomas S; Krum H; Kelly DJ; Gilbert RE
    Cardiovasc Ther; 2013 Apr; 31(2):84-91. PubMed ID: 21884026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should angiotensin converting enzyme (ACE) inhibitors be used routinely after infarction? Perspectives from the Survival and Ventricular Enlargement (SAVE) trial.
    Sutton MS
    Br Heart J; 1994 Feb; 71(2):115-8. PubMed ID: 8130017
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibitors as cardioprotective agents.
    Massie BM
    Am J Cardiol; 1992 Dec; 70(21):10I-17I. PubMed ID: 1471600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Issues surrounding a local cardiac renin system and the beneficial actions of angiotensin-converting enzyme inhibitors in ischemic myocardium.
    Sweet CS
    Am J Cardiol; 1990 May; 65(19):11I-13I. PubMed ID: 2186609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How do ACE inhibitors reduce mortality in patients with left ventricular dysfunction with and without heart failure: remodelling, resetting, or sudden death?
    Cleland JG; Puri S
    Br Heart J; 1994 Sep; 72(3 Suppl):S81-6. PubMed ID: 7946810
    [No Abstract]   [Full Text] [Related]  

  • 15. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When to start an ACE inhibitor and in whom.
    Wilson PA
    Cardiovasc Drugs Ther; 1994 Feb; 8(1):111-4. PubMed ID: 8086320
    [No Abstract]   [Full Text] [Related]  

  • 17. Is there a link between the circulating renin-angiotensin system and coronary disease? A buoyant view.
    Alderman MH
    Heart; 1996 Nov; 76(3 Suppl 3):18-22. PubMed ID: 8977361
    [No Abstract]   [Full Text] [Related]  

  • 18. Importance of RAA system and the treatment of patients with ACE inhibition after myocardial infarction.
    Ray SG; McAlpine HM; Morton JJ; Leckie B; Dargie HJ
    Angiology; 1991 Apr; 42(4):268-72. PubMed ID: 2014917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin converting enzyme inhibitors and cardiovascular remodelling.
    Vaughan DE; Pfeffer MA
    Cardiovasc Res; 1994 Feb; 28(2):159-65. PubMed ID: 8143295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial hypertrophy, angiotensin, and ACE inhibitors.
    Re RN
    Angiology; 1993 Nov; 44(11):875-81. PubMed ID: 8239059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.